CARA Cara Therapeutics Inc: Bozor qiymatining balans qiymatiga nisbati
Cara Therapeutics, Inc. (CARA) sintez uchun tashqi CMO ob'ektlaridan foydalangan holda, virtual dori ishlab chiqish modeli asosida faoliyat yuritadi. Ushbu GURU.Markets terminal grafigi bozor kapitalizatsiyasining sof aktivlarga nisbati bo'yicha ma'lumotlarni taqdim etadi, bunda ushbu ko'rsatkich hozirda 0.90 ni tashkil etgan. O'sish nefrologiya markazlarining sodiqligi bilan ta'minlanmoqda, inson kapitali esa tadqiqot kimyogarlari uchun optsion tizimi orqali saqlab qolinmoqda.
Cara Therapeutics Inc. (CARA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Cara Therapeutics, Inc.|CARA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Cara Therapeutics, Inc|CARA - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Cara Therapeutics, Inc|CARA - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Cara Therapeutics|Tezkor likvidlik caratherapeutics.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Cara Therapeutics, Inc. - CARA
P/BV koeffitsiyenti emitentning bozor qiymatini uning sof aktivlariga solishtirib, kapitalga nisbatan premium yoki diskontni aniqlaydi. Tarixiy P/BV darajasini tahlil qilish orqali investor aktivlar sifatini va ularning qiymati pasayishi xavfini baholaydi. Cara Therapeutics, Inc. (CARA) uchun ushbu koeffitsiyentning pasayishi klinik sinovlardagi muvaffaqiyatsizliklar tufayli tijorat salohiyatining yo'qolganini aks ettiradi. Platformaga bo'lgan ishonchning pasayishi kompaniyaning iqtisodiy ustunligini yo'q qilmoqda, bu esa uzoq muddatli turg'unlikning yuqori ehtimolligidan dalolat beradi.
Asosiy raqobatchilar
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|neurocrine.com (NBIX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati trevitherapeutics.com (TRVI)|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|Bozor kapitallashuvining balans qiymatiga nisbati Anavex (AVXL)|Bozor qiymatining balans qiymatiga nisbati CeriBell Corp CBLL|Balans qiymatiga nisbatan bozor qiymati PRTA|Alector Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ANNX - Bozor kapitallashuvining balans qiymatiga nisbati|OMER (omeros.com) - Kapitallashuvning sof aktivlarga nisbati|Neurogene Inc - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ACIU|VYGR (Voyager Corp) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati NMRA|SCLX (scilexholding.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TVGN (Tevogen Bio)|Alpha Cognition Inc (ACOG) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CGTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IKT (Inhibikase Pharma)|SAVA: Bozor kapitallashuvining balans qiymatiga nisbati|Assertio (ASRT) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Coya Therapeutics Inc|VistaGen Therapeutics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati OVID|ABOS - Bozor qiymatining balans qiymatiga koeffitsiyenti|CervoMed Inc. - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Alterity Therapeutics Ltd. ATHE|CLNN: Kapitallashuvning sof aktivlarga nisbati|PepGen Inc. - Bozor kapitallashuvining balans qiymatiga multiplikatori|JUNS: Bozor kapitallashuvining balans qiymatiga nisbati|RLMD - Balans qiymatiga nisbatan bozor kapitallashuvi|ANVS (Annovis Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Grace Tx (GRCE)|Bozor qiymatining balans qiymatiga nisbati Firefly Neuroscience (AIFF)|Balans qiymatiga nisbatan bozor kapitallashuvi anewmeds.com|NeuroSense Therapeutics Ltd. - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RVPH|MetaVia, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi neuraxis.com NRXS|heliusmedical.com (HSDT) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati PASG|NEUP (Neuphoria Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Minerva (NERV)|Kapitallashuvning sof aktivlarga nisbati ATHA (Athira Pharma, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi addextherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati ALZN (Alzamend Neuro)|CYCN - Kapitallashuvning sof aktivlarga nisbati|Protagenic - Bozor kapitallashuvining balans qiymatiga nisbati|KTTA - Bozor kapitallashuvining balans qiymatiga nisbati|cortigent.com (CRGT) - Bozor qiymatining balans qiymatiga nisbati|avenuetx.com - Balans qiymatiga nisbatan bozor qiymati|BCLI (BrainStorm Cell Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Chromocell Therapeutics Corp|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics (ELYM)|intracellulartherapies.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati LBPH (Longboard Pharmaceuticals)|marinuspharma.com (MRNS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGN: Kapitallashuvning sof aktivlarga nisbati|NRBO - Bozor kapitallashuvining balans qiymatiga nisbati|Sage Therapeutics, Inc (SAGE) - Bozor qiymatining balans qiymatiga nisbati|Synaptogenix, Inc - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro VIGL|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Kapitallashuvning sof aktivlarga nisbati Cerevel Therapeutics Inc CERE